SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1989. Upgrade now.
Date Value
March 31, 2024 2.483B
December 31, 2023 2.804B
September 30, 2023 2.519B
June 30, 2023 2.702B
March 31, 2023 2.479B
December 31, 2022 2.687B
September 30, 2022 2.52B
June 30, 2022 2.512B
March 31, 2022 2.323B
December 31, 2021 2.83B
September 30, 2021 2.336B
June 30, 2021 2.281B
March 31, 2021 2.187B
December 31, 2020 2.619B
September 30, 2020 2.06B
June 30, 2020 2.085B
March 31, 2020 2.555B
December 31, 2019 1.729B
September 30, 2019 2.589B
June 30, 2019 2.712B
March 31, 2019 2.425B
December 31, 2018 2.643B
September 30, 2018 2.443B
June 30, 2018 2.508B
March 31, 2018 2.508B
Date Value
December 31, 2017 2.642B
September 30, 2017 2.459B
June 30, 2017 2.50B
March 31, 2017 2.472B
December 31, 2016 2.848B
September 30, 2016 2.393B
June 30, 2016 2.458B
March 31, 2016 2.318B
December 31, 2015 2.615B
September 30, 2015 2.472B
June 30, 2015 2.624B
March 31, 2015 2.601B
December 31, 2014 2.925B
September 30, 2014 2.975B
June 30, 2014 2.973B
March 31, 2014 2.734B
December 31, 2013 2.982B
September 30, 2013 2.803B
June 30, 2013 3.14B
March 31, 2013 2.987B
December 31, 2012 3.39B
September 30, 2012 3.063B
June 30, 2012 3.249B
March 31, 2012 3.074B
December 31, 2011 3.704B

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.729B
Minimum
Dec 2019
2.83B
Maximum
Dec 2021
2.451B
Average
2.516B
Median

SG&A Expense (Quarterly) Benchmarks

Amgen Inc 1.808B
Johnson & Johnson 5.057B
Eli Lilly and Co 1.836B
Pfizer Inc 3.495B
Moderna Inc 274.00M